Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines

By Leroux-Roels G.   Desombere I.   Cobbaut L.   Petit M.-A.   Desmons P.   Hauser P.   Delem A.   De Grave D.   Safary A.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1732-1736

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''Reactogenicity and immunogenicity of adult versus paediatric diptheria and tetanus booster dose at 6 years of age'' [Vaccine 20 (2002) 74-79]

By Ciofi degli Atti M.L.   Salmaso S.   Cotter B.   Gallo G.   Alfarone G.   Pinto A.   Bella A.   von Hunolstein C.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 989-989

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin'' [Vaccine 20 (2002) 446-457]

By Sheoran A.S.   Artiushin S.   Timoney J.F.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2230-2230

Elsevier

Access to resources Recommend Favorite

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

By Hilleman M.R.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1436-1447

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL ( R) adjuvant'' [Vaccine 20 (2002) 3292-3303]

By Skeiky Y.A.W.   Coler R.N.   Brannon M.   Stromberg E.   Greeson K.   Thomas Crane R.   Webb J.R.   Campos-Neto A.   Reed S.G.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3783-3783

Elsevier

Access to resources Recommend Favorite